Department of Pharmacy, Harborview Medical Center, Box 359885, Seattle, WA 98104, USA.
J Crit Care. 2010 Jun;25(2):363.e9-363.e14. doi: 10.1016/j.jcrc.2009.07.007. Epub 2009 Sep 24.
Little is known about how published evidence regarding use of steroids in septic shock has been incorporated into clinical practice.
All patients admitted to an intensive care unit at a single, tertiary-care, academic medical center from November 1, 2004, through February 28, 2005, were screened using the hospital's computerized pharmacy database to determine if they had received at least 1 qualifying medication: cosyntropin, fludrocortisone, hydrocortisone, or dopamine, epinephrine, or norepinephrine as a vasopressor infusion.
Only 58% (95% confidence interval, 47%-69%) of the 81 patients who met criteria for vasopressor-dependent septic shock (VDSS) were evaluated for critical illness-related corticosteroid insufficiency. Forty-seven percent of the 81 patients who met the criteria for VDSS and 49% of the 47 patients who did not meet the criteria for VDSS were treated with corticosteroids. Nearly all (85%; 95% confidence interval, 72%-94%) patients who did not meet the criteria for VDSS received an adrenocorticotropic hormone test.
Treatment and evaluation of critical illness-related corticosteroid insufficiency in critically ill patients at our institution are inconsistent. Many patients with VDSS do not receive either treatment or evaluation for critical illness-related corticosteroid insufficiency, and patients who do not meet the current criteria are being evaluated and/or treated for critical illness-related corticosteroid insufficiency.
对于发表的关于脓毒性休克中使用类固醇的证据是如何纳入临床实践的,人们知之甚少。
2004 年 11 月 1 日至 2005 年 2 月 28 日期间,从一家三级学术医疗中心的重症监护病房中筛选了所有符合条件的患者,使用医院的计算机化药房数据库确定他们是否至少接受了一种合格药物治疗:促皮质素、氟氢可的松、氢化可的松或多巴胺、肾上腺素或去甲肾上腺素作为血管加压素输注。
仅 81 名符合血管加压素依赖性脓毒性休克(VDSS)标准的患者中的 58%(95%置信区间,47%-69%)接受了危重病相关皮质激素不足的评估。符合 VDSS 标准的 81 名患者中有 47%和不符合 VDSS 标准的 47 名患者中有 49%接受了皮质激素治疗。不符合 VDSS 标准的几乎所有患者(85%;95%置信区间,72%-94%)都接受了促肾上腺皮质激素试验。
在我们的机构中,对危重病患者的危重病相关皮质激素不足的治疗和评估是不一致的。许多符合 VDSS 标准的患者既没有接受治疗,也没有接受危重病相关皮质激素不足的评估,而不符合当前标准的患者正在接受评估和/或治疗危重病相关皮质激素不足。